Prevalence and clinical outcomes of secondary infections associated with covid 19 in patients admitted to ICU.
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 250
- 试验地点
- 1
- 主要终点
- Prevalence of secondary infection and microbiological species
研究概览
简要总结
This is an observational study. All confirmed cases of COVID 19 patients admitted to ICU will be included in the study. Patient’s general information and medical history will be extracted from the patient’s record and includes age, gender and other co-morbidities.
The following data will be collected from the time of ICU admission: Date of ICU admission, temperature, GCS, SOFA and APACHE II score and detailed clinical findings at admission.
The investigations, complications developed during the ICU stay and the treatment the patient underwent in ICU will be captured.
The primary outcome measured prevalence of secondary infection, source of infection, commonest bacterial and fungal species causing these infections.
The secondary outcome measured - In-ICUmortality, ICU length of stay
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 99.00 Year(s)（—）
- 性别
- All
入选标准
- •All patients confirmed positive for COVID 19 disease admitted to the ICU.
排除标准
- •patients tested negative for COVID 19 disease.
结局指标
主要结局
Prevalence of secondary infection and microbiological species
时间窗: after 4 weeks
次要结局
- ICU mortality rate and ICU length of stay(After 4weeks)